Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Resistance of the interface device used to deliver nasal continuous positive airway pressure or nasal intermittent ventilation.

Perl H.

J Pediatr. 2018 Feb;193:277. doi: 10.1016/j.jpeds.2017.10.045. Epub 2017 Dec 1. No abstract available.

PMID:
29198535
2.

Predictors of 12-Step Attendance and Participation for Individuals With Stimulant Use Disorders.

Hatch-Maillette M, Wells EA, Doyle SR, Brigham GS, Daley D, DiCenzo J, Donovan D, Garrett S, Horigian VE, Jenkins L, Killeen T, Owens M, Perl HI.

J Subst Abuse Treat. 2016 Sep;68:74-82. doi: 10.1016/j.jsat.2016.06.007. Epub 2016 Jun 16.

3.

Transdisciplinary translational behavioral (TDTB) research: opportunities, barriers, and innovations.

Czajkowski SM, Lynch MR, Hall KL, Stipelman BA, Haverkos L, Perl H, Scott MS, Shirley MC.

Transl Behav Med. 2016 Mar;6(1):32-43. doi: 10.1007/s13142-015-0367-3. Review.

4.

Enhancing Coordination Among the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, and National Institutes of Health.

Murray DM, Kaplan RM, Ngo-Metzger Q, Portnoy B, Olkkola S, Stredrick D, Kuczmarski RJ, Goldstein AB, Perl HI, O'Connell ME.

Am J Prev Med. 2015 Sep;49(3 Suppl 2):S166-73. doi: 10.1016/j.amepre.2015.04.024.

5.

Brief intervention for patients with problematic drug use presenting in emergency departments: a randomized clinical trial.

Bogenschutz MP, Donovan DM, Mandler RN, Perl HI, Forcehimes AA, Crandall C, Lindblad R, Oden NL, Sharma G, Metsch L, Lyons MS, McCormack R, Macias-Konstantopoulos W, Douaihy A.

JAMA Intern Med. 2014 Nov;174(11):1736-45. doi: 10.1001/jamainternmed.2014.4052. Erratum in: JAMA Intern Med. 2015 Mar;175(3):470. Macias Konstantopoulos, Wendy [Corrected to Macias-Konstantopoulos, Wendy].

6.

Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?

Wells EA, Donovan DM, Daley DC, Doyle SR, Brigham G, Garrett SB, Ingalsbe MH, Hatch-Maillette MA, Perl HI, Walker R.

J Subst Abuse Treat. 2014 Oct;47(4):265-74. doi: 10.1016/j.jsat.2014.06.003. Epub 2014 Jun 14.

7.

Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol.

Donovan DM, Bogenschutz MP, Perl H, Forcehimes A, Adinoff B, Mandler R, Oden N, Walker R.

Addict Sci Clin Pract. 2012 Aug 28;7:16. doi: 10.1186/1940-0640-7-16.

8.

Stimulant abuser groups to engage in 12-step: a multisite trial in the National Institute on Drug Abuse Clinical Trials Network.

Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Garrett SB, Doyle SR, Floyd AS, Knox PC, Botero C, Kelly TM, Killeen TK, Hayes C, Kau'i Baumhofer N, Seamans C, Zammarelli L.

J Subst Abuse Treat. 2013 Jan;44(1):103-14. doi: 10.1016/j.jsat.2012.04.004. Epub 2012 May 31. Erratum in: J Subst Abuse Treat. 2015 Feb;49:71. Kau'ibaumhofer, Nicole [corrected to Kau'i Baumhofer, Nicole].

9.

Design of NIDA CTN Protocol 0047: screening, motivational assessment, referral, and treatment in emergency departments (SMART-ED).

Bogenschutz MP, Donovan DM, Adinoff B, Crandall C, Forcehimes AA, Lindblad R, Mandler RN, Oden NL, Perl HI, Walker R.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):417-25. doi: 10.3109/00952990.2011.596971.

10.

How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.

Donovan DM, Daley DC, Brigham GS, Hodgkins CC, Perl HI, Floyd AS.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):408-16. doi: 10.3109/00952990.2011.596970.

11.

Randomized multi-site trial of the Job Seekers' Workshop in patients with substance use disorders.

Svikis DS, Keyser-Marcus L, Stitzer M, Rieckmann T, Safford L, Loeb P, Allen T, Luna-Anderson C, Back SE, Cohen J, DeBernardi MA, Dillard B, Forcehimes A, Jaffee W, Killeen T, Kolodner K, Levy M, Pallas D, Perl HI, Potter JS, Provost S, Reese K, Sampson RR, Sepulveda A, Snead N, Wong CJ, Zweben J.

Drug Alcohol Depend. 2012 Jan 1;120(1-3):55-64. doi: 10.1016/j.drugalcdep.2011.06.024. Epub 2011 Jul 29.

12.

Addicted to discovery: Does the quest for new knowledge hinder practice improvement?

Perl HI.

Addict Behav. 2011 Jun;36(6):590-6. doi: 10.1016/j.addbeh.2011.01.027. Epub 2011 Feb 1.

PMID:
21349648
13.

Addiction treatment trials: how gender, race/ethnicity, and age relate to ongoing participation and retention in clinical trials.

Korte JE, Rosa CL, Wakim PG, Perl HI.

Subst Abuse Rehabil. 2011 Nov 22;2:205-18. doi: 10.2147/SAR.S23796. eCollection 2011.

14.

A Combined Group and Individual 12-Step Facilitative Intervention Targeting Stimulant Abuse in the NIDA Clinical Trials Network: STAGE-12.

Daley DC, Stuart Baker MA, Donovan DM, Hodgkins CG, Perl H.

J Groups Addict Recover. 2011;6(3):228-244. Epub 2011 Aug 29. No abstract available.

15.

Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.

Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl H, Nugent CD, Pintello D, Condon TP.

J Subst Abuse Treat. 2010 Jun;38 Suppl 1:S31-43. doi: 10.1016/j.jsat.2009.12.013.

16.

Concurrent risks in sudden infant death syndrome.

Ostfeld BM, Esposito L, Perl H, Hegyi T.

Pediatrics. 2010 Mar;125(3):447-53. doi: 10.1542/peds.2009-0038. Epub 2010 Feb 15.

PMID:
20156907
17.

Sleep environment, positional, lifestyle, and demographic characteristics associated with bed sharing in sudden infant death syndrome cases: a population-based study.

Ostfeld BM, Perl H, Esposito L, Hempstead K, Hinnen R, Sandler A, Pearson PG, Hegyi T.

Pediatrics. 2006 Nov;118(5):2051-9.

PMID:
17079578
18.

Challenges applying alcohol brief intervention in diverse practice settings: populations, outcomes, and costs.

Saitz R, Svikis D, D'Onofrio G, Kraemer KL, Perl H.

Alcohol Clin Exp Res. 2006 Feb;30(2):332-8.

PMID:
16441282
19.

Ask the right questions and make good use of the answers: a response to Humphreys & Tucker.

Perl HI, Hilton ME.

Addiction. 2002 Feb;97(2):134-6; discussion 138-40. No abstract available.

PMID:
11860381
20.
21.

State-of-the-art methodologies in alcohol-related health services research.

Perl HI, Dennis ML, Huebner RB.

Addiction. 2000 Nov;95 Suppl 3:S275-80. Review.

PMID:
11132358
22.

Constructing quantitative implementation scales from categorical services data. Examples from a multisite evaluation.

Orwin RG, Sonnefeld LJ, Cordray DS, Pion GM, Perl HI.

Eval Rev. 1998 Apr;22(2):245-88. Review.

PMID:
10183306
23.
24.
25.

Curriculum issues in community psychology: the ecology of program development and the socialization of students.

Trickett EJ, Irving JB, Perl HI.

Am J Community Psychol. 1984 Apr;12(2):141-55. No abstract available.

PMID:
6731365
26.

A synthetic resorcinol-formaldehyde resin for the absorption of urea from hemofiltrate.

Armstrong VW, Fuchs C, Klüver H, Nussbaumer D, Perl H, Rieger J, Scheler F.

Contrib Nephrol. 1982;32:181-5. No abstract available.

PMID:
7128156
27.

[Studies on mineral excretion in mineral-free feeding in grown pigs].

Molnár S, Lantzsch HJ, Perl H, Gütte JO, Lenkeit W.

Z Tierphysiol Tierernahr Futtermittelkd. 1967 Jun;22(5):313-20. German. No abstract available.

PMID:
5634226
28.

[The influence of Kaolinite on the digESTIBILITY OF INORGANIC SUBSTANCES BY GROWN PIGS].

Lenkeit W, Günther K, Bruhn GA, Perl H.

Z Tierphysiol Tierernahr Futtermittelkd. 1967 Apr;22(4):242-9. German. No abstract available.

PMID:
5633623

Supplemental Content

Support Center